NHL.N0000 Share Price | Nawaloka Hospitals Plc Stock Analysis & Recommendation

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

With a growth in Net Sales of 15.85%, the company declared Very Positive results in Dec 25

NET PROFIT(HY) Higher at LKR 429.53 MM
ROCE(HY) Highest at 24.04%
RAW MATERIAL COST(Y) Fallen by -13.61% (YoY)

With ROE of 5.97%, it has a very expensive valuation with a 2.30 Price to Book Value

Market Beating Performance

Mojo Parameters

Stock DNA

Industry

Hospital

Market cap

LKR 16,350 Million (Mid Cap)

P/E

39.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

1.26

Return on Equity

-999,999.00%

Price to Book

2.69

Revenue and Profits:

Net Sales:

3,438 Million

(Quarterly Results - Dec 2025)

Net Profit:

140 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

5.41%

6 Months

30.0%

1 Year

112.73%

2 Years

192.5%

3 Years

108.93%

4 Years

72.06%

5 Years

125.0%

Nawaloka Hospitals Plc for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

8.55%

EBIT Growth (5y)

17.98%

EBIT to Interest (avg)

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

Tax Ratio

Tax Ratio is Negative%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.30

EV to EBIT

14.96

EV to EBITDA

7.77

EV to Capital Employed

1.54

EV to Sales

2.08

PEG Ratio

Dividend Yield

ROCE (Latest)

10.28%

ROE (Latest)

5.97%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bullish

No Trend

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -2.78% vs 19.51% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -52.55% vs -59.96% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,438.40",
          "val2": "3,536.90",
          "chgp": "-2.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "847.40",
          "val2": "884.70",
          "chgp": "-4.22%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "208.10",
          "val2": "267.80",
          "chgp": "-22.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "5.30",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "139.60",
          "val2": "294.20",
          "chgp": "-52.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "160.60%",
          "val2": "170.60%",
          "chgp": "-1.00%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 6.10% vs 11.54% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 118.51% vs 87.50% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "11,012.70",
          "val2": "10,379.20",
          "chgp": "6.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,693.40",
          "val2": "1,863.40",
          "chgp": "-9.12%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "927.90",
          "val2": "1,491.40",
          "chgp": "-37.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.40",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "56.40",
          "val2": "-304.70",
          "chgp": "118.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "78.80%",
          "val2": "96.60%",
          "chgp": "-1.78%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]